tradingkey.logo

Stereotaxis Inc

STXS
View Detailed Chart

2.800USD

+0.040+1.45%
Close 09/18, 16:00ETQuotes delayed by 15 min
240.80MMarket Cap
LossP/E TTM

Stereotaxis Inc

2.800

+0.040+1.45%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.45%

5 Days

-2.78%

1 Month

+0.72%

6 Months

+51.35%

Year to Date

+22.81%

1 Year

+43.59%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated2025-09-18

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
73 / 207
Overall Ranking
193 / 4721
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 4 analysts
Buy
Current Rating
4.500
Target Price
+63.04%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
Growing
The company is in a growing phase, with the latest annual income totaling USD 26.92M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 29.12.
Undervalued
The company’s latest PE is -9.87, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 70.71M shares, increasing 15.91% quarter-over-quarter.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
Ticker SymbolSTXS
CompanyStereotaxis Inc
CEOMr. David Leo Fischel
Websitehttps://www.stereotaxis.com/
KeyAI